Anvisa to Develop Standards and Guidelines for Nanotechnology Products

This content is provided by RegLink News, publishers of e-weekly global regulatory news. RegLink offers a 30-day free trial and 15% discount on Global Update subscriptions to RAPS members.

Brazil’s national regulatory agency, Anvisa, has established a multidisciplinary Nanotechnology Committee within the agency with the mandate to develop standards and specific guidelines for the evaluation and regulation of products that use nanotechnology. 

In addition to the standards and guidance, the Committee must also create a database on nanopartícles or nanomaterials used in health-related products, develop a training plan for Anvisa staff, and address other matters relating to nanotechnolgy. The Committee has a deadline of one year to complete its assigned tasks.